Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference
TEL AVIV, Israel, May 02, 2024 (GLOBE NEWSWIRE) — Chemomab Therapeutics Ltd. (Nasdaq:CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that Chief Executive Officer Dr. Adi Mor will deliver a corporate presentation at the Aegis Virtual Conference on May 7, 2024 at 9:00 am ET. Dr. Mor’s presentation will be webcast live. The registration link to access the live presentation is included below and is also available at the Events section of the Chemomab website.